Complement C5-deficient mice are protected from seizures in experimental cerebral malaria

Susan C Buckingham1, Theresa N Ramos, Scott R Barnum

  • 1Department of Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.

Epilepsia
|November 12, 2014
PubMed

Insights

The membrane attack complex (MAC) causes seizures. Inhibiting MAC formation in cerebral malaria models significantly reduced seizure activity, suggesting a therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Infectious Diseases

Background:

  • The membrane attack complex (MAC) is known to induce seizures when directly applied to the brain.
  • Experimental cerebral malaria (ECM) is associated with neurological complications, including seizures.

Purpose of the Study:

  • To investigate the role of the MAC in seizures occurring during experimental cerebral malaria (ECM).
  • To determine if inhibiting the terminal complement pathway affects seizure frequency in ECM.

Main Methods:

  • Long-term video-electroencephalography (EEG) was used to monitor seizure activity.
  • Comparison of seizure frequency between C5-deficient mice (lacking MAC formation) and wild-type mice infected with Plasmodium berghei ANKA.

Main Results:

  • C5-deficient mice exhibited significantly reduced spike and seizure frequency compared to wild-type mice during ECM.
  • This indicates a correlation between MAC formation and seizure activity in ECM.

Conclusions:

  • The MAC plays a role in mediating seizures associated with malaria.
  • Inhibiting the terminal complement pathway may be a viable strategy to reduce seizures and associated neurocognitive deficits in ECM.